A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Meena B Bansal, Guy W Neff, Dominic Labriola, Sam E Moussa, Alessandra Mangia, Rebecca Taub, Michael R Charlton, Rashmee Patil, Mary E Rinella, Vlad Ratziu, Cynthia D Guy, Philip N Newsome, Pierre Bedossa, Sven Francque, Laurent Castera, Naim Alkhouri, Nicolas Lanthier, Arun J Sanyal, Mazen Noureddin, Juan M Pericàs, Quentin M Anstee, Stephen A Harrison, Seth J Baum, Manal F Abdelmalek, Rohit Loomba, Zobair Younossi, Jörn M Schattenberg, Ingolf Schiefke, Madhavi Rudraraju
The New England journal of medicine 2024;390(6):497-509